Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates
Viking Therapeutics VKTX reported second-quarter 2024 loss per share of 20 cents, narrower than the Zacks Consensus Estimate of a loss of 26 cents. The company had incurred a loss of 19 cents per shar...